Heart health: How Could New Treatments for Transform Cardiovascular Risk Management?
Recent advancements in treatments for lipoprotein(a) may alter how we assess and manage cardiovascular health, potentially reducing risks…
cholesterol
Cholesterol: Why is , specifically Lp(a), the new focus for heart drug developers?
Pharmaceutical companies are now targeting Lp(a), a lesser-known form of cholesterol, to develop innovative heart medications. This shift…